Qureator
Latest round
- Series A
Last raised
- Jan 2021
Total raised
- $6.3M
Investors
- 6
About Qureator
, operates as a drug development company. In June 2026, Qureator, Inc. at KRW 32 billion post-money. As of 2021, the company’s CEO is Kyu-Seok Baek. Qureator provides curiochips, which are micro-physiological systems (MPS) for drug development procedures. The company provides organ-on-a-chip microfluidic platforms that include T-Curio, which is a 3D co-culture platform that consists of 16 testing wells; S-Curio, which is a 3D co-culture platform that consists of eight testing wells; 96-Curio, which is a 3D co-culture that consists of eight testing wells that consist of three patterning lanes; and Custom-Curio. In addition, the company offers an AI-enabled platform that leverages deep learning frameworks for providing users with data management solutions.
Who invested in Qureator
6 investors across 2 rounds
See all investors in Qureator
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Qureator
Who invested in Qureator?
Qureator has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Qureator raised?
Qureator has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Qureator last raise money?
Qureator's most recent round on record is a Series A, in Jan 2021.
What does Qureator do?
, operates as a drug development company.
Where is Qureator headquartered?
Qureator is headquartered in San Diego, US.
Which VCs invest in companies like Qureator?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Qureator's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Qureator? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.